264 related articles for article (PubMed ID: 7896811)
21. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts.
Ito A; Yamada M; Sato T; Sanekata K; Sato H; Seiki M; Nagase H; Mori Y
Eur J Biochem; 1998 Jan; 251(1-2):353-8. PubMed ID: 9492304
[TBL] [Abstract][Full Text] [Related]
22. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
23. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
24. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
25. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
26. Activation of human matrix metalloproteinases by various bacterial proteinases.
Okamoto T; Akaike T; Suga M; Tanase S; Horie H; Miyajima S; Ando M; Ichinose Y; Maeda H
J Biol Chem; 1997 Feb; 272(9):6059-66. PubMed ID: 9038230
[TBL] [Abstract][Full Text] [Related]
27. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice.
Lijnen HR; Silence J; Van Hoef B; Collen D
Blood; 1998 Mar; 91(6):2045-53. PubMed ID: 9490689
[TBL] [Abstract][Full Text] [Related]
28. Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72 kDa gelatinase) by ovine endometrial cells in vitro: different regulation and preferential expression by stromal fibroblasts.
Salamonsen LA; Nagase H; Suzuki R; Woolley DE
J Reprod Fertil; 1993 Jul; 98(2):583-9. PubMed ID: 8410828
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
30. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
[TBL] [Abstract][Full Text] [Related]
31. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
[TBL] [Abstract][Full Text] [Related]
32. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
34. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B.
Lees M; Taylor DJ; Woolley DE
Eur J Biochem; 1994 Jul; 223(1):171-7. PubMed ID: 8033891
[TBL] [Abstract][Full Text] [Related]
35. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
[TBL] [Abstract][Full Text] [Related]
37. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
[TBL] [Abstract][Full Text] [Related]
38. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
39. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms for pro matrix metalloproteinase activation.
Murphy G; Stanton H; Cowell S; Butler G; Knäuper V; Atkinson S; Gavrilovic J
APMIS; 1999 Jan; 107(1):38-44. PubMed ID: 10190278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
